As CD10 inactivates a number of ECM factors by cleaving amino-terminal peptide bonds and facilitating tumor progression, FGF in particular, it could be assumed that it is involved in blocking FGF-mediated angiogenesis and hence promoting the invasive potential of these neoplasms in a two-hit mechanism [28]. Here, MME is linked to neoplasm.